| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |